Latest KFF Health News Stories
What’s at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
KFF Health News' 'What the Health?': Less Than Two Weeks To Go
With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.
Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers
Poppy seeds contaminated with opioids can be used to make a deadly brew, a watchdog says.
FDA’s Promised Guidance on Pulse Oximeters Unlikely To End Decades of Racial Bias
For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?
Por qué se habla de discriminación racial al tomar el nivel de oxígeno
Fiscales estatales y senadores de EE.UU. han presionado a la Administración de Drogas y Alimentos para que tome medidas que ayuden a eliminar la desviación racial en los oxímetros de pulso.
Setting the Record Straight on the FDA’s Authority Over Drug Ads
KFF Health News gives readers a chance to comment on a recent batch of stories.
Unpacking the FDA’s Non-Recall Recalls
When the Agriculture Department posted a recall of chicken nuggets that might be contaminated, it directed consumers to return them or throw the stuff away. When the Consumer Product Safety Commission announced that poorly designed baby loungers could suffocate babies, it warned consumers to immediately stop using them. But when it comes to medical devices, […]
With TV Drug Ads, What You See Is Not Necessarily What You Get
The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.
En los comerciales de medicamentos en TV, lo que ves no siempre es lo que es
Los anuncios de medicamentos han sido omnipresentes en la televisión desde finales de la década de 1990 y se han extendido a internet y las redes sociales. Pocas naciones en el mundo los permiten
Journalists Discuss African Mpox Upsurge, EpiPen Alternative, and Medicaid Unwinding
KFF Health News and California Healthline staff made the rounds on national and state media this week to discuss topical stories. Here’s a collection of their appearances.
The FDA Calls Them ‘Recalls,’ Yet the Targeted Medical Devices Often Remain in Use
With medical devices, recalls are not always what they seem. In some recalls, including some of the most serious, the FDA and the manufacturers let doctors and hospitals continue to use the devices.
Inside Project 2025: Former Trump Official Outlines Hard Right Turn Against Abortion
Former President Donald Trump has distanced himself from a Heritage Foundation document that outlines positions on abortion and a range of other social issues. But Democrats view it as a window into the far right’s to-do list and a clear opening for political attack.
The CDC’s Test for Bird Flu Works, but It Has Issues
The Centers for Disease Control and Prevention promises better tests are being developed, but the episode points to vulnerabilities in the country’s defense against emerging outbreaks.
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs
Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.
Qué son los medicamentos compuestos que millones de personas usan para bajar de peso
La FDA permite e incluso fomenta que las farmacias de compuestos produzcan y vendan copias cuando un medicamento está en escasez, como es el caso de las drogas para combatir el sobrepeso y la obesidad.
From Dr. Oz to Heart Valves: A Tiny Device Charted a Contentious Path Through the FDA
The story of MitraClip, a device Dr. Oz helped invent to treat faulty heart valves, is a cautionary tale about the science, business, and regulation of medical technology.
KFF Health News' 'What the Health?': SCOTUS Term Wraps With a Bang
The Supreme Court has issued its final opinions for the 2023-24 term, including decisions affecting abortion access, the opioid epidemic, and how the federal government functions. In this special episode, Sarah Somers , legal director of the National Health Law Program, joins KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss how the justices disposed of the term’s health-related cases and what those decisions could mean going forward.
The Supreme Court Just Limited Federal Power. Health Care Is Feeling the Shockwaves.
A Supreme Court ruling restricting federal power will likely have seismic ramifications for health policy. A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations they say are too expensive or burdensome and not authorized by law — could leave the country with a patchwork of disparate health regulations.
KFF Health News' 'What the Health?': SCOTUS Ruling Strips Power From Federal Health Agencies
In what will certainly be remembered as a landmark decision, the Supreme Court has overruled a 40-year-old precedent that gave federal agencies, rather than judges, the power to interpret ambiguous laws passed by Congress. Administrative experts say the decision will dramatically change the way key health agencies do business. Also, the court decided not to decide whether a federal law requiring hospitals to provide emergency care overrides Idaho’s near-total ban on abortion. Alice Miranda Ollstein of Politico, Victoria Knight of Axios, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
KFF Health News' 'What the Health?': SCOTUS Rejects Abortion Pill Challenge — For Now
The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.
